Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer

Cell Cycle

Volumn 10, Issue 17, 2011, Pages 2865-2873

  Jordan, Nicole Vincent ^a   Johnson, Gary L ^a   Abell, Amy N ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

CBP; Claudin low breast cancer; EMT; EMT and stemness; Epigenetics; Histone acetylation; MAP3K4; Metastable EMT; TS cells

Indexed keywords

ACTIN; CELL PROTEIN; CLAUDIN; GLYCOPROTEIN; NERVE CELL ADHESION MOLECULE; PROTEIN MAP 3K4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNAI 1; TRANSCRIPTION FACTOR SNAI 2; TRANSCRIPTION FACTOR ZEB 1; TRANSCRIPTION FACTOR ZEB 2; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

CANCER CELL; CANCER GROWTH; CELL ACTIVATION; CELL DIFFERENTIATION; CELL POLARITY; CELL RENEWAL; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FIBROSIS; HISTONE ACETYLATION; HUMAN; NEOPLASM; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TRANSCRIPTION REGULATION; TROPHOBLAST;

EID: 80052423435     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.17.17188     Document Type: Review

References (103)

1. Thiery J.P., Acloque H., Huang R.Y.J., Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139:871-90; PMID:19945376; DOI:10.1016/j.cell.2009.11.007.
2. Thiery J.P., Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7:131-42; PMID:16493418; DOI:10.1038/ nrm1835.
3. Hay ED. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 2005; 233:706-20; PMID:15937929; DOI:10.1002/dvdy.20345.
4. Kalluri R., Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119:1420-8; PMID:19487818; DOI:10.1172/JCI39104.
5. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133:704-15; PMID:18485877; DOI:10.1016/j. cell.2008.03.027.
6. Lee J.M., Dedhar S., Kalluri R., Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development and disease. J Cell Biol 2006; 172:973-81; PMID:16567498; DOI:10.1083/ jcb.200601018.
7. Abell A.N., Jordan N.V., Huang W., Prat A., Midland A.A., Johnson N.L., et al. MAP3K4/CBP-Regulated H2B Acetylation Controls Epithelial-Mesenchymal Transition in Trophoblast Stem Cells. Cell Stem Cell 2011; 8:525-37; PMID:21549327; DOI:10.1016/j. stem.2011.03.008.
8. Abell A.N., Granger D.A., Johnson N.L., Vincent-Jordan N., Dibble C.F., Johnson GL. Trophoblast Stem Cell Maintenance by Fibroblast Growth Factor 4 Requires MEKK4 Activation of Jun N-Terminal Kinase. Mol Cell Biol 2009; 29:2748-61; PMID:19289495; DOI:10.1128/MCB.01391-08.
9. Acloque H., Adams M.S., Fishwick K., Bronner-Fraser M., Nieto MA. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 2009; 119:1438-49; PMID:19487820; DOI:10.1172/JCI38019.
10. Zeisberg M., Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009; 119:1429-37; PMID:19487819; DOI:10.1172/JCI36183.
11. Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 2009; 119:1417- 9; PMID:19487817; DOI:10.1172/JCI39675.
12. Timmerman L.A., Grego-Bessa J., Raya A., Bertrán E., Pérez-Pomares J.M., Díez J., et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev 2004; 18:99-115; PMID:14701881; DOI:10.1101/ gad.276304.
13. Zavadil J., Böttinger EP. TGFβ and epithelial-to-mesenchymal transitions. Oncogene 2005; 24:5764-74; PMID:16123809; DOI:10.1038/sj.onc. 1208927.
14. Zavadil J., Cermak L., Soto-Nieves N., Böttinger EP. Integration of TGFbeta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 2004; 23:1155-65; PMID:14976548; DOI:10.1038/ sj.emboj.7600069.
15. Fuxe J., Vincent T., Garcia de Herreros A. Transcriptional crosstalk between TGFβ and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle 2010; 9:2363-74; PMID:20519943; DOI:10.4161/cc.9.12.12050.
16. Rossant J., Cross JC. Placental development: lessons from mouse mutants. Nat Rev Genet 2001; 2:538-48; PMID:11433360; DOI:10.1038/35080570.
17. Gonzales D.S., Jones J.M., Pinyopummintr T., Carnevale E.M., Ginther O.J., Shapiro S.S., et al. Trophectoderm projections: a potential means for locomotion, attachment and implantation of bovine, equine and human blastocysts. Hum Reprod 1996; 11:2739-2745; PMID:9021382.
18. Pafilis J., Batistatou A., Iliopoulou A., Tsanou E., Bakogiannis A., Dassopoulos G., et al. Expression of adhesion molecules during normal pregnancy. Cell Tissue Res 2007; 329:1-11; PMID:17406899; DOI:10.1007/s00441-007-0406-6.
19. Sutherland A. Mechanisms of implantation in the mouse: differentiation and functional importance of trophoblast giant cell behavior. Dev Biol 2003; 258:241-51; PMID:12798285; DOI:10.1016/S0012- 1606(03)00130-1.
20. Zhou Y., Fisher S.J., Janatpour M., Genbacev O., Dejana E., Wheelock M., et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 1997; 99:2139-51; PMID:9151786; DOI:10.1172/ JCI119387.
21. Goldman-Wohl D., Yagel S. Regulation of trophoblast invasion: from normal implantation to preeclampsia. Mol Cell Endocrinol 2002; 187:233- 8; PMID:11988332; DOI:10.1016/S0303- 7207(01)00687-6.
22. McMaster M.T., Zhou Y., Fisher SJ. Abnormal placentation and the syndrome of preeclampsia. Semin Nephrol 2004; 24:540-7; PMID:15529288; DOI:10.1016/ S0270-9295(04)00124-X.
23. Zhou Y., Damsky C.H., Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 1997; 99:2152-64; PMID:9151787; DOI:10.1172/ JCI119388.
24. Khong TY. The pathology of placenta accreta, a worldwide epidemic. J Clin Pathol 2008; 61:1243-6; PMID:18641410; DOI:10.1136/jcp.2008.055202.
25. Perry J.K., Lins R.J., Lobie P.E., Mitchell MD. Regulation of invasive growth: similar epigenetic mechanisms underpin tumour progression and implantation in human pregnancy. Clin Sci 2009; 118:451-7; PMID:20025611; DOI:10.1042/CS20090503.
26. Ferretti C., Bruni L., Dangles-Marie V., Pecking A.P., Bellet D. Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum Reprod Update 2007; 13:121-41; PMID:17068222; DOI:10.1093/humupd/dml048.
27. Rossant J. Stem cells and lineage development in the mammalian blastocyst. Reprod Fertil Dev 2007; 19:111-8; PMID:17389140; DOI:10.1071/RD06125.
28. Erlebacher A., Price K.A., Glimcher LH. Maintenance of mouse trophoblast stem cell proliferation by TGFbeta/ activin. Dev Biol 2004; 275:158-69; PMID:15464579; DOI:10.1016/j.ydbio.2004.07.032.
29. Tanaka S., Kunath T., Hadjantonakis A.K., Nagy A., Rossant J. Promotion of Trophoblast Stem Cell Proliferation by FGF4. Science 1998; 282:2072-5; PMID:9851926; DOI:10.1126/science.282.5396.2072.
30. Kokkinos M.I., Murthi P., Wafai R., Thompson E.W., Newgreen DF. Cadherins in the human placenta-epithelial-mesenchymal transition (EMT) and placental development. Placenta 2010; 31:747- 55; PMID:20659767; DOI:10.1016/j.placenta. 2010.06.017.
31. Larue L., Ohsugi M., Hirchenhain J., Kemler R. E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc Natl Acad Sci USA 1994; 91:8263-7; PMID:8058792; DOI:10.1073/ pnas.91.17.8263.
32. Shih I.M., Hsu M.Y., Oldt R.J., Herlyn M., Gearhart J.D., Kurman R.J. The Role of E-cadherin in the Motility and Invasion of Implantation Site Intermediate Trophoblast. Placenta 2002; 23:706-715; PMID:12398810.
33. Abell A.N., Rivera-Perez J.A., Cuevas B.D., Uhlik M.T., Sather S., Johnson N.L., et al. Ablation of MEKK4 kinase activity causes neurulation and skeletal patterning defects in the mouse embryo. Mol Cell Biol 2005; 25:8948-59; PMID:16199873; DOI:10.1128/ MCB.25.20.8948-59.2005.
34. Niwa H., Toyooka Y., Shimosato D., Strumpf D., Takahashi K., Yagi R., et al. Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell 2005; 123:917-29; PMID:16325584; DOI:10.1016/j.cell.2005. 08.040.
35. Ralston A., Rossant J. Cdx2 acts downstream of cell polarization to cell-autonomously promote trophectoderm fate in the early mouse embryo. Dev Biol 2008; 313:614-29; PMID:18067887; DOI:10.1016/j. ydbio.2007.10.054.
36. Hajra K.M., Chen D.Y.S., Fearon E.R. The SLUG zincfinger protein represses E-cadherin in breast cancer. Cancer Res 2002; 62:1613-1618; PMID:11912130.
37. Nieto MA. THE SNAIL SUPERFAMILY OF ZINCFINGER TRANSCRIPTION FACTORS. Nat Rev Mol Cell Biol 2002; 3:155-66; PMID:11994736; DOI:10.1038/nrm757.
38. Peinado H., Olmeda D., Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7:415-28; PMID:17508028; DOI:10.1038/nrc2131.
39. Vandewalle C., Van Roy F., Berx G. The role of the ZEB family of transcription factors in development and disease. Cell Mol Life Sci 2009; 66:773-87; PMID:19011757; DOI:10.1007/s00018-008-8465-8.
40. Vandewalle C., Comijn J., De Craene B., Vermassen P., Bruyneel E., Andersen H., et al. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cellcell junctions. Nucleic Acids Res 2005; 33:6566-78; PMID:16314317; DOI:10.1093/nar/gki965.
41. Battula V.L., Evans K.W., Hollier B.G., Shi Y., Marini F.C., Ayyanan A., et al. Epithelial-Mesenchymal Transition-Derived Cells Exhibit Multilineage Differentiation Potential Similar to Mesenchymal Stem Cells. Stem Cells 2010; 28:1435-45; PMID:20572012; DOI:10.1002/stem.467.
42. Taube J.H., Herschkowitz J.I., Komurov K., Zhou A.Y., Gupta S., Yang J., et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA 2010; 107:15449-54; PMID:20713713; DOI:10.1073/pnas. 1004900107.
43. Medici D., Hay E.D., Goodenough DA. Cooperation between snail and LEF-1 transcription factors is essential for TGFbeta1-induced epithelial-mesenchymal transition. Mol Biol Cell 2006; 17:1871-9; PMID:16467384; DOI:10.1091/mbc.E05- 08-0767.
44. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125:315-26; PMID:16630819; DOI:10.1016/j. cell.2006.02.041.
45. Heredia F., Nieto MA. An epigenetic mark that protects the epithelial phenotype in health and disease. Cell Stem Cell 2011; 8:462-3; PMID:21549319; DOI:10.1016/j.stem.2011.04.011.
46. Hemberger M. Genetic-epigenetic intersection in trophoblast differentiation: implications for extraembryonic tissue function. Epigenetics 2010; 5:24-9; PMID:20083894; DOI:10.4161/epi.5.1.10589.
47. Hemberger M. Epigenetic landscape required for placental development. Cell Mol Life Sci 2007; 64:2422-36; PMID:17585370; DOI:10.1007/s00018-007-7113- z.
48. Chapman V., Forrester L., Sanford J., Hastie N., Rossant J. Cell lineage-specific undermethylation of mouse repetitive DNA. Nature 1984; 307:284-6; PMID:6694730; DOI:10.1038/307284a0.
49. Ng R.K., Dean W., Dawson C., Lucifero D., Madeja Z., Reik W., et al. Epigenetic restriction of embryonic cell lineage fate by methylation of Elf5. Nat Cell Biol 2008; 10:1280-90; PMID:18836439; DOI:10.1038/ ncb1786.
50. Rossant J., Sanford J.P., Chapman V.M., Andrews GK. Undermethylation of structural gene sequences in extraembryonic lineages of the mouse. Dev Biol 1986; 117:567-73; PMID:2428685; DOI:10.1016/0012- 1606(86)90325-8.
51. Santos F., Hendrich B., Reik W., Dean W. Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev Biol 2002; 241:172-82; PMID:11784103; DOI:10.1006/dbio.2001.0501.
52. Arima T., Hata K., Tanaka S., Kusumi M., Li E., Kato K., et al. Loss of the maternal imprint in Dnmt3Lmat-/- mice leads to a differentiation defect in the extraembryonic tissue. Dev Biol 2006; 297:361-73; PMID:16920095; DOI:10.1016/j.ydbio.2006.05.003.
53. Bourc'his D., Xu G.L., Lin C.S., Bollman B., Bestor TH. Dnmt3L and the establishment of maternal genomic imprints. Science 2001; 294:2536-9; PMID:11719692; DOI:10.1126/science.1065848.
54. Hata K., Okano M., Lei H., Li E. Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice. Development 2002; 129:1983-1993; PMID:11934864.
55. O'Carroll D., Erhardt S., Pagani M., Barton S.C., Surani M.A., Jenuwein T. The polycomb-group gene Ezh2 is required for early mouse development. Mol Cell Biol 2001; 21:4330-6; PMID:11390661; DOI:10.1128/ MCB.21.13.4330-6.2001.
56. Pasini D., Bracken A.P., Jensen M.R., Lazzerini Denchi E., Helin K. Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J 2004; 23:4061-71; PMID:15385962; DOI:10.1038/ sj.emboj.7600402.
57. Wang J., Mager J., Schnedier E., Magnuson T. The mouse PcG gene eed is required for Hox gene repression and extraembryonic development. Mamm Genome 2002; 13:493-503; PMID:12370779; DOI:10.1007/s00335- 002-2182-7.
58. Wang J., Mager J., Chen Y., Schneider E., Cross J.C., Nagy A., et al. Imprinted X inactivation maintained by a mouse Polycomb group gene. Nat Genet 2001; 28:371-5; PMID:11479595; DOI:10.1038/ng574.
59. Rugg-Gunn P.J., Cox B.J., Ralston A., Rossant J. Inaugural Article: Distinct histone modifications in stem cell lines and tissue lineages from the early mouse embryo. Proc Natl Acad Sci USA 2010; 107:10783-90; PMID:20479220; DOI:10.1073/pnas.0914507107.
60. Kalantry S., Mills K.C., Yee D., Otte A.P., Panning B., Magnuson T. The Polycomb group protein Eed protects the inactive X-chromosome from differentiationinduced reactivation. Nat Cell Biol 2006; 8:195-202; PMID:16415857; DOI:10.1038/ncb1351.
61. Hebbes T.R., Thorne A.W., Crane-Robinson C. A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J 1988; 7:1395-1402; PMID:3409869.
62. Lee D.Y., Hayes J.J., Pruss D., Wolffe AP. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 1993; 72:73-84; PMID:8422685; DOI:10.1016/0092- 8674(93)90051-Q.
63. Giles R.H., Peters D.J., Breuning MH. Conjunction dysfunction: CBP/p300 in human disease. Trends Genet 1998; 14:178-83; PMID:9613201; DOI:10.1016/ S0168-9525(98)01438-3.
64. Tanaka Y., Naruse I., Maekawa T., Masuya H., Shiroishi T., Ishii S. Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein-Taybi syndrome. Proc Natl Acad Sci USA 1997; 94:10215-20; PMID:9294190; DOI:10.1073/pnas.94.19.10215.
65. Ansieau S., Bastid J., Doreau A., Morel A.P., Bouchet B.P., Thomas C., et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 2008; 14:79-89; PMID:18598946; DOI:10.1016/j.ccr.2008.06.005.
66. Smit M.A., Peeper D.S. Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths. Aging (Albany NY) 2010; 2:735-741; PMID:20975209.
67. Smit M.A., Peeper DS. Deregulating EMT and senescence: double impact by a single twist. Cancer Cell 2008; 14:5-7; PMID:18598938; DOI:10.1016/j. ccr.2008.06.012.
68. Li R., Liang J., Ni S., Zhou T., Qing X., Li H., et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 2010; 7:51-63; PMID:20621050; DOI:10.1016/j.stem.2010.04.014.
69. Samavarchi-Tehrani P., Golipour A., David L, Sung Hk, Beyer TA, Datti A, et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 2010; 7:64-77; PMID:20621051; DOI:10.1016/j.stem.2010.04.015.
70. Strumpf D., Mao C.A., Yamanaka Y., Ralston A., Chawengsaksophak K., Beck F., et al. Cdx2 is required for correct cell fate specification and differentiation of trophectoderm in the mouse blastocyst. Development 2005; 132:2093-102; PMID:15788452; DOI:10.1242/dev.01801.
71. Brabletz T., Jung A., Reu S., Porzner M., Hlubek F, Kunz- Schughart LA, et al. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 2001; 98:10356-61; PMID:11526241; DOI:10.1073/ pnas.171610498.
72. Zlobec I., Lugli A. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget. Oncotarget 2010; 1:651-661; PMID:21317460.
73. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100:3983-8; PMID:12629218; DOI:10.1073/ pnas.0530291100.
74. Hennessy B.T., Gonzalez-Angulo AM, Stemke- Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS, et al. Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics. Cancer Res 2009; 69:4116-24; PMID:19435916; DOI:10.1158/0008-5472.CAN-08-3441.
75. Pang R., Law W.L., Chu A.C.Y., Poon J.T., Lam C.S.C., Chow A.K.M., et al. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 2010; 6:603-15; PMID:20569697; DOI:10.1016/j.stem.2010.04.001.
76. Prat A., Parker J.S., Karginova O., Fan C., Livasy C., Herschkowitz J.I., et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010; 12:68; PMID:20813035; DOI:10.1186/bcr2635.
77. Reya T., Morrison S.J., Clarke M.F., Weissman IL. Stem cells, cancer and cancer stem cells. Nature 2001; 414:105-11; PMID:11689955; DOI:10.1038/35102167.
78. Sheridan C., Kishimoto H., Fuchs R.K., Mehrotra S., Bhat-Nakshatri P., Turner C.H., et al. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 2006; 8:59; PMID:17062128; DOI:10.1186/bcr1610.
79. Morel A.P., Lièvre M., Thomas C., Hinkal G., Ansieau S., Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 2008; 3:2888; PMID:18682804; DOI:10.1371/journal. pone.0002888.
80. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2:442-54; PMID:12189386; DOI:10.1038/nrc822.
81. Yang J., Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008; 14:818-29; PMID:18539112; DOI:10.1016/j.devcel.2008.05.009.
82. Bianchi A., Gervasi M.E., Bakin A. Role of β5-integrin in epithelial-mesenchymal transition in response to TGFβ. Cell Cycle 2010; 9:1647-59; PMID:20404485; DOI:10.4161/cc.9.8.11517.
83. Côme C., Magnino F., Bibeau F., De Santa Barbara P., Becker K.F., Theillet C., et al. Snail and slug play distinct roles during breast carcinoma progression. Clin Cancer Res 2006; 12:5395-402; PMID:17000672; DOI:10.1158/1078-0432.CCR-06-0478.
84. De Craene B., Gilbert B., Stove C., Bruyneel E., Van Roy F., Berx G. The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. Cancer Res 2005; 65:6237-44; PMID:16024625; DOI:10.1158/0008-5472.CAN-04-3545.
85. Moll R, Mitze M, Frixen UH, Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 1993; 143:1731-1742; PMID:8256859.
86. Moody S.E., Perez D, Pan Tc, Sarkisian CJ, Portocarrero CP, Sterner CJ, et al. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 2005; 8:197-209; PMID:16169465; DOI:10.1016/j. ccr.2005.07.009.
87. Novak A., Hsu S.C., Leung-Hagesteijn C., Radeva G., Papkoff J., Montesano R., et al. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and betacatenin signaling pathways. Proc Natl Acad Sci USA 1998; 95:4374-9; PMID:9539744; DOI:10.1073/ pnas.95.8.4374.
88. Peinado H., Quintanilla M., Cano A. Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J Biol Chem 2003; 278:21113-23; PMID:12665527; DOI:10.1074/jbc.M211304200.
89. Prall F. Tumour budding in colorectal carcinoma. Histopathology 2007; 50:151-62; PMID:17204028; DOI:10.1111/j.1365-2559.2006.02551.x.
90. Turner FE. Slug Regulates Integrin Expression and Cell Proliferation in Human Epidermal Keratinocytes. J Biol Chem 2006; 281:21321-31; PMID:16707493; DOI:10.1074/jbc.M509731200.
91. Vuoriluoto K., Haugen H., Kiviluoto S., Mpindi J.P., Nevo J., Gjerdrum C., et al. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 2011; 30:1436-48; PMID:21057535; DOI:10.1038/ onc.2010.509.
92. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117:927-39; PMID:15210113; DOI:10.1016/j.cell.2004. 06.006.
93. Bonnomet A., Brysse A., Tachsidis A., Waltham M., Thompson E.W., Polette M., et al. Epithelial-to- Mesenchymal Transitions and Circulating Tumor Cells. J Mammary Gland Biol Neoplasia 2010; 15:261-73; PMID:20449641; DOI:10.1007/s10911-010-9174-0.
94. Willipinski-Stapelfeldt B., Riethdorf S., Assmann V., Woelfle U., Rau T., Sauter G., et al. Changes in cytoskeletal protein composition indicative of an epithelialmesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res 2005; 11:8006-14; PMID:16299229; DOI:10.1158/1078-0432.CCR-05-0632.
95. Wyckoff J.B., Wang Y., Lin EY, Li Jf, Goswami S, Stanley ER, et al. Direct visualization of macrophageassisted tumor cell intravasation in mammary tumors. Cancer Res 2007; 67:2649-56; PMID:17363585; DOI:10.1158/0008-5472.CAN- 06-1823.
96. Burleigh AR. Of germ cells, trophoblasts and cancer stem cells. Integr Cancer Ther 2008; 7:276-81; PMID:19116223; DOI:10.1177/1534735408326454.
97. Campbell L.L., Polyak K. Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell Cycle 2007; 6:2332-8; PMID:17786053; DOI:10.4161/ cc.6.19.4914.
98. Floor S., Van Staveren W.C., Larsimont D., Dumont J.E., Maenhaut C. Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating- cancer stem cells: Distinct, overlapping or same populations. Oncogene 2011; In Press; PMID:21643013; DOI:10.1038/ onc.2011.184.
99. Visvader JE. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev 2009; 23:2563-77; PMID:19933147; DOI:10.1101/ gad.1849509.
100. Visvader J.E., Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8:755-68; PMID:18784658; DOI:10.1038/nrc2499.
101. Baritaki S., Huerta-Yepez S., Sahakyan A., Karagiannides I., Bakirtzi K., Jazirehi A., et al. Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: Inhibition of the metastasis-inducer Snail and induction of the metastasis-suppressor RKIP. Cell Cycle 2010; 9:4931-40; PMID:21150329; DOI:10.4161/ cc.9.24.14229.
102. Halder S.K., Beauchamp R.D., Datta PK. A specific inhibitor of TGFβ receptor kinase, SB-431542, as a potent antitumor agent for human cancers. Neoplasia 2005; 7:509-21; PMID:15967103; DOI:10.1593/ neo.04640.
103. Stoops S.L., Pearson A.S., Weaver C., Waterson A.G., Days E., Farmer C., et al. Identification and optimization of small molecules that restore e-cadherin expression and reduce invasion in colorectal carcinoma cells. ACS Chem Biol 2011; 6:452-65; PMID:21241068; DOI:10.1021/cb100305h.